间变性淋巴瘤激酶抑制剂用于间变性淋巴瘤激酶阳性晚期非小细胞肺癌患者一线治疗的临床综合评价研究
叶子奇, 周昱君, 刘浏, 张燕芳, 洪昀, 饶跃峰
Comprehensive Evaluation of ALK Inhibitors in the First-line Treatment of Patients with ALK-positive Non-small Cell Lung Cancer
YE Ziqi, ZHOU Yujun, LIU Liu, ZHANG Yanfang, HONG Yun, RAO Yuefeng
中国全科医学
.
2026, (29): 4258
-4264
.
DOI: 10.12114/j.issn.1007-9572.2025.0201
